Pregled bibliografske jedinice broj: 1058442
Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis)
Percutaneous Coronary Intervention and Outcomes in Patients With Lymphoma in the United States (Nationwide Inpatient Sample [NIS] Analysis) // The American journal of cardiology, 124 (2019), 8; 1190-1197 doi:10.1016/j.amjcard.2019.07.015 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1058442 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Percutaneous Coronary Intervention and Outcomes
in Patients With Lymphoma in the United States
(Nationwide Inpatient Sample [NIS] Analysis)
Autori
Borovac, Josip Anđelo ; Kwok, Chun Shing ; Iliescu, Cezar ; Lee, Hun Ju ; Kim, Peter Y. ; Palaskas, Nicolas L. ; Zaman, Azfar ; Butler, Robert ; Lopez-Mattei, Juan C. ; Mamas, Mamas A.
Izvornik
The American journal of cardiology (0002-9149) 124
(2019), 8;
1190-1197
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
percutaneous coronary intervention ; PCI ; lymphoma ; outcomes ; in-hospital mortality ; periprocedural outcomes
Sažetak
Characteristics and outcomes of patients with lymphoma undergoing percutaneous coronary intervention (PCI) are unknown. Therefore, we analyzed clinical characteristics and outcomes in patients that underwent PCI and had a concomitant diagnosis of Hodgkin's (HL) or non- Hodgkin's (NHL) lymphoma. We analyzed patients with and without lymphoma diagnosis from the Nationwide Inpatient Sample in the United States who underwent PCI procedure during 2004 to 2014. Multivariable regression analysis was performed to examine the association between lymphoma diagnosis and clinical outcomes post- PCI including short-term complications and in- hospital mortality. A total of 7, 119, 539 PCI procedures were included in the analysis and 18, 052 patients had a diagnosis of lymphoma (0.25%). These patients were likely to experience in-hospital mortality (odds ratio [OR] 1.39, 95% confidence interval [CI] 1.25 to 1.54), stroke or transient ischemic attack (OR 1.75, 95% CI 1.61 to 1.90), and any in-hospital complication (OR 1.31, 95% CI 1.25 to 1.37), following PCI. In the lymphoma subtype- analysis, diagnosis of HL was associated with an increased odds of in-hospital death (OR 1.40, 95% CI 1.24 to 1.56), any in-hospital complication (OR 1.31, 95% CI 1.25 to 1.38), bleeding complications (OR 1.12 95% CI 1.05 to 1.20), and vascular complications (OR 1.13 95% CI 1.06 to 1.20) whereas these odds were not significantly associated with non-Hodgkin's diagnosis. Finally, both types of lymphoma were associated with increased odds of stroke/transient ischemic attack following PCI (OR 1.82, 95% CI 1.67 to 1.99 and OR 1.31, 95% CI 1.05 to 1.63, respectively). In conclusion, while the prevalence of lymphoma in the observed PCI cohort was low, a diagnosis of lymphoma was associated with an adverse prognosis following PCI, primarily in patients with the HL diagnosis.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
KBC Split,
Medicinski fakultet, Split
Profili:
Josip Anđelo Borovac
(autor)
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE